| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/31/2001 | US6267959 Monoclonal antibodies having property of causing apoptosis and used as anticancer agents |
| 07/31/2001 | US6267957 Attaching agents to tissue with transglutaminase and a transglutaminase substrate |
| 07/31/2001 | US6267956 For prevention, diagnosis, and treatment of pathophysiological disorders related to apoptosis |
| 07/31/2001 | US6267955 Mononuclear phagocytes and their use to promote axonal regeneration |
| 07/31/2001 | CA2218372C Antagonists of human interleukin-6 that are totally incapable of binding gp 130, and their use in the preparation of pharmaceutical compounds |
| 07/31/2001 | CA2161136C Adenoviruses having modified fiber proteins |
| 07/31/2001 | CA2122058C Tgf-beta to improve neural outcome |
| 07/31/2001 | CA2118119C Methods for treating interleukin-1 and tumor necrosis factor mediated diseases |
| 07/31/2001 | CA2107553C Monoclonal antibodies to stem cell factor receptors |
| 07/31/2001 | CA2069428C A mammalian cytokine, il-11 |
| 07/31/2001 | CA2041989C Aqueous pharmaceutical formulations of erythropoietin and the use thereof |
| 07/31/2001 | CA2024667C Process for preparing a concentrate of blood coagulation factor viii-von willebrand factor complex from total plasma |
| 07/26/2001 | WO2001054403A1 Method and system for providing a customized media list |
| 07/26/2001 | WO2001053835A2 Methods for detecting cancer of the central nervous system |
| 07/26/2001 | WO2001053541A1 Antisense modulation of caspase 8 expression |
| 07/26/2001 | WO2001053540A1 Antisense modulation of pepck-cytosolic expression |
| 07/26/2001 | WO2001053530A1 Human protein tyrosine phosphatase polynucleotides, polypeptides, and antibodies |
| 07/26/2001 | WO2001053528A1 Antisense inhibition of ptp1b expression |
| 07/26/2001 | WO2001053515A1 Methods and materials relating to novel interleukin-1 receptor-like polypeptides and polynucleotides |
| 07/26/2001 | WO2001053506A2 Virus strains for the oncolytic treatment of cancer |
| 07/26/2001 | WO2001053505A2 Herpes virus strains for gene therapy |
| 07/26/2001 | WO2001053500A1 Methods and materials relating to stem cell growth factor-like poypeptides and polynucleotides |
| 07/26/2001 | WO2001053499A1 Novel polypeptide---human proliferating-cell nucleolar protein 18 and polynucleotide encoding it |
| 07/26/2001 | WO2001053498A1 Novel polypeptide-ef-chiral calcium-binding protein 42 and polynucleotide encoding it |
| 07/26/2001 | WO2001053497A1 Novel polypeptide---human zinc finger protein 57 containing bola structural domain and polynucleotide encoding it |
| 07/26/2001 | WO2001053496A1 Novel polypeptide---human sodium neuro:transmitter cotransporter protein 8,43 and polynucleotide encoding it |
| 07/26/2001 | WO2001053493A2 Human kinase protein and polynucleotides encoding the same |
| 07/26/2001 | WO2001053492A1 A novel polypeptide, s-adenosylmethionine synthetase 31 and the polynucleotide encoding the polypeptide |
| 07/26/2001 | WO2001053490A1 Genes encoding abc1 paralogs and the polypeptides derived therefrom |
| 07/26/2001 | WO2001053489A1 Human gaba receptor proteins and polynucleotides encoding the same |
| 07/26/2001 | WO2001053487A2 Human sperm specific lysozyme-like proteins |
| 07/26/2001 | WO2001053485A1 Methods and materials relating to novel von willebrand/thrombospondin-like polypeptides and polynucleotides |
| 07/26/2001 | WO2001053483A1 A novel polypeptide, a human zinc finger protein 30 and the polynucleotide encoding the polypeptide |
| 07/26/2001 | WO2001053477A1 Methods and compositions for control of bone formation via modulation of neuropeptide y activity |
| 07/26/2001 | WO2001053469A2 Phosphatases |
| 07/26/2001 | WO2001053468A2 Lipid metabolism enzymes and polynucleotides encoding them |
| 07/26/2001 | WO2001053467A1 Recombinant flaviviruses and methods of use thereof |
| 07/26/2001 | WO2001053466A1 Methods and materials relating to semaphorin-like polypeptides and polynucleotides |
| 07/26/2001 | WO2001053458A2 Methods and reagents for performing antimicrobial compound screening |
| 07/26/2001 | WO2001053456A2 Methods and materials relating to prothrombinase-like polypeptides and polynucleotides |
| 07/26/2001 | WO2001053455A2 Novel nucleic acids and polypeptides |
| 07/26/2001 | WO2001053453A2 Novel bone marrow nucleic acids and polypeptides |
| 07/26/2001 | WO2001053352A2 Sperm specific proteins |
| 07/26/2001 | WO2001053351A2 Apoptin bindendes protein |
| 07/26/2001 | WO2001053350A1 Myostatin and mimetics thereof |
| 07/26/2001 | WO2001053349A2 Small cell lung cancer associated antigens and uses therefor |
| 07/26/2001 | WO2001053348A2 Human polypeptides related to the vanilloid and trp families of cation channel proteins and nucleic acids encoding them |
| 07/26/2001 | WO2001053347A2 Nphs2 gene involved in the cortico-resistant neprhotic syndrome, protein encoded by said gene and diagnostic and therapeutic uses |
| 07/26/2001 | WO2001053346A1 Human cystine knot polypeptide |
| 07/26/2001 | WO2001053345A1 Vegf148 isoform, a truncated splice variant of vegf. vegf heterodimers and therapeutical uses thereof |
| 07/26/2001 | WO2001053344A2 Chondromodulin-i related peptide |
| 07/26/2001 | WO2001053343A1 Human polynucleotides, polypeptides, and antibodies |
| 07/26/2001 | WO2001053342A1 Chimeric prostate-homing peptides with pro-apoptotic activity |
| 07/26/2001 | WO2001053341A1 A new polypeptide-human zinc finger protein 13 and the polynucleotide encoding it |
| 07/26/2001 | WO2001053336A1 Clostridial toxin derivatives and methods for treating pain |
| 07/26/2001 | WO2001053335A2 Peptides with antibacterial activity |
| 07/26/2001 | WO2001053334A1 thdF |
| 07/26/2001 | WO2001053331A2 Peptidomimetic modulators of cell adhesion |
| 07/26/2001 | WO2001053330A2 High purity lipopeptides, lipopeptide micelles, processes for preparing same and pharmaceutical compositions containing them |
| 07/26/2001 | WO2001053328A1 Process for the purification of antothrombin-iii |
| 07/26/2001 | WO2001053326A1 Methods and materials relating to phospholipase-like polypeptides and polynucleotides |
| 07/26/2001 | WO2001053324A2 Novel haptotactic peptides |
| 07/26/2001 | WO2001053322A2 Aerothricin analogs, their preparation and use |
| 07/26/2001 | WO2001053317A1 Antisense modulation of macrophage migration inhibitory factor expression |
| 07/26/2001 | WO2001053313A1 Antisense modulation of smad7 expression |
| 07/26/2001 | WO2001053311A1 Antisense modulation of peroxisome proliferator-activated receptor gamma expression |
| 07/26/2001 | WO2001053310A1 Antisense modulation of caspase 3 expression |
| 07/26/2001 | WO2001053297A1 Alpha v integrin receptor antagonists |
| 07/26/2001 | WO2001053255A1 Gamma-secretase inhibitors |
| 07/26/2001 | WO2001053254A1 Calcilytic compounds |
| 07/26/2001 | WO2001052937A1 Mixed buffer system for stabilizing polypeptide formulations |
| 07/26/2001 | WO2001052904A2 Pharmaceutical compositions and methods of treatment based on vegf antisense oligonucleotides |
| 07/26/2001 | WO2001052902A1 Antisense modulation of inducible nitric oxide synthase expression |
| 07/26/2001 | WO2001052901A1 Drugs for gene therapy |
| 07/26/2001 | WO2001052894A2 Nasally administrable cyclic peptide compositions |
| 07/26/2001 | WO2001052892A2 Jak/stat pathway inhibitors and the uses thereof |
| 07/26/2001 | WO2001052890A1 Heat shock/stress protein complexes as vaccines against neurodegenerative disorders |
| 07/26/2001 | WO2001052883A1 Inhibitors of protease-activated receptor-2 (par-2) as novel asthma therapeutics |
| 07/26/2001 | WO2001052882A1 Combination of temozolomide and pegylated interferon-alpha for treating cancer |
| 07/26/2001 | WO2001052881A1 Interferon-alpha use in the treatment of ewing's family of tumors |
| 07/26/2001 | WO2001052880A1 Cyclic peptides as potent and selective melanocortin-4 receptor antagonists |
| 07/26/2001 | WO2001052879A1 Use of emap ii receptor antagonist composition for treating pulmonary hypertension |
| 07/26/2001 | WO2001052878A2 The use of copolymer 1 and related peptides and polypeptides and t cells treated therewith for neuroprotective therapy |
| 07/26/2001 | WO2001052877A1 Compositions and methods to treat neurodegenerative disorders |
| 07/26/2001 | WO2001052875A1 Vegf-d/vegf-c/vegf peptidomimetic inhibitor |
| 07/26/2001 | WO2001052874A2 Intra-tumoral administration of il-12 encoding nucleic acid molecules |
| 07/26/2001 | WO2001052865A1 Antisense modulation of glycogen synthase kinase 3 alpha expression |
| 07/26/2001 | WO2001052864A1 Antisense modulation of cot oncogene expression |
| 07/26/2001 | WO2001052863A1 Antisense modulation of mekk2 expression |
| 07/26/2001 | WO2001052862A1 Antisense modulation of glycogen synthase kinase 3 beta expression |
| 07/26/2001 | WO2001052843A1 β-TURN PEPTIDOMIMETIC CYCLIC COMPOUNDS |
| 07/26/2001 | WO2001052842A1 Compositions for the prevention of diaper dermatitis |
| 07/26/2001 | WO2001052835A2 Free radical scavengers for the treatment of premature birth |
| 07/26/2001 | WO2001052808A1 Treatment of uv induced immunosuppression |
| 07/26/2001 | WO2001052791A2 Complexes of peptide-binding fragments of heat shock proteins and their use as immunotherapeutic agents |
| 07/26/2001 | WO2001052789A2 PAX8-PPARη NUCLEIC ACID MOLECULES AND POLYPEPTIDES AND USES THEREOF |
| 07/26/2001 | WO2001052746A1 Versatile hydrophilic dyes |
| 07/26/2001 | WO2001052664A1 Immune modulation with death receptor-induced apoptosis |
| 07/26/2001 | WO2001052639A1 Use of pro-apoptotic factors in treatment of atherosclerosis |
| 07/26/2001 | WO2001052616A2 Novel nucleic acids and polypeptides |